A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

NCT03598621 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide, 0.5 mg/mL
DRUG: Semaglutide, 1.0 mg/mL
DRUG: Semaglutide, 1.34 mg/mL
DRUG: Semaglutide, 2.0 mg/mL
DEVICE: DV3372, 0.5 mg/mL
DEVICE: DV3372, 1.0 mg/mL
DEVICE: PDS290
DEVICE: NovoPen®4

Sponsor

Novo Nordisk A/S